| Name | Y08284 |
|---|
| Description | Y08284 is a potent, selective, oral active CBP bromodomain inhibitor with an IC50 of 4.21 nM. Y08284 suppresses the proliferation of prostate cancer cell lines LNCaP, C4-2B, and 22Rv1. Antitumor activity[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Y08284 demonstrates favorable cell permeability and good pharmacokinetic properties, with oral bioavailability of 25.9%[1]. |
| References |
| Molecular Formula | C26H25FN4O4 |
|---|---|
| Molecular Weight | 476.50 |